🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 69 of 173

  1. US 10034934

    Porcine epidemic diarrhea virus vaccines and methods of use thereof

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10035846

    Humanized pertussis antibodies and uses thereof

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10035823

    Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10035981

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10034916

    Methods of treating a retinal disease by retinal pigment epithelial stem cells

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10030054

    Campylobacter immunogenic compositions and uses thereof

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10028992

    Methods of treating muscular dystrophy

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10028936

    Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10028980

    Compositions and methods for transplantation of colon microbiota

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10028983

    Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10029017

    Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10030089

    Sugar free, statistical copolymers made from at least three monomers

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10023637

    Combination immunotherapy for the treatment of cancer

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10022325

    Compositions and methods for the treatment of cancer

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10023652

    Method of targeting glycoproteins to treat cancer

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10022385

    Thermo-kinetic mixing for pharmaceutical applications

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10022450

    Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10023581

    Modified cytotoxins and their therapeutic use

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10023588

    Compositions and methods for treating cancer

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10017551

    Peptides having reduced toxicity that stimulate cholesterol efflux

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10017598

    Block copolymer and micelle compositions and methods of use thereof

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10018638

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10016461

    Apparatus and process for growing a heart valve in three-dimensions

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10016452

    Fibromodulin formulation for reducing corneal scarring

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10016486

    Methods and compositions using AMPK activators for pharmacological prevention of chronic pain

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10016490

    Multiple-enzyme nanocomplexes

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10016498

    D-amino acid derivative-modified peptidoglycan and methods of use thereof

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10011589

    Treatments for gastrointestinal conditions

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10011649

    High affinity synbodies for influenza

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10010534

    Intravenous formulation and LC/MS/MS analysis method for GMC1

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10010595

    Live recombinant booster vaccine against tuberculosis

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10010629

    Compositions and methods for in vivo imaging

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10012653

    Nanoparticles for targeting acid tumor microenvironments

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10010525

    Methods of inducing anesthesia

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10005735

    Inhibitors of RPN11

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10004751

    Compositions and methods for treating Dengue virus infection

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10004785

    LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10005745

    Amyloid targeting agents and methods of using the same

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10005741

    Therapeutic compounds

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10005833

    Methods of treating inflammation associated airway diseases and viral infections

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10005838

    Milk fat globule epidermal growth factor 8 regulates fatty acid uptake

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10004775

    Inhibition of hypoxia-inducible factor activity with carica papaya extracts

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10004687

    Liposomal curcumin for treatment of diseases

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10000772

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10000582

    Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10001485

    Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10000534

    Peptide having osteoblast proliferation activity and periodontal ligament fibroblast proliferation activity, and use of same

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9999639

    Cellular extracts

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.